Survivors of out-of-hospital cardiac arrest (OHCA) without ST-segment elevation who were transported to the nearest hospital emergency department had similar outcomes as those transported to specialist […]

Pulsed field ablation (PFA), a technology now approved in Europe but not yet licensed in the United States, achieved noninferiority to conventional thermal ablation for the […]

AMSTERDAM — Another drug for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) has shown encouraging results in a phase 3 trial. The drug, acoramidis (BridgeBio Pharma), […]

Patients with acute myocardial infarction (MI) and shock are often put on extracorporeal membrane oxygenation (ECMO) support before heading to the catheterization laboratory. But the practice, […]

The European Society of Cardiology (ESC) has issued new guidelines for the prevention, diagnosis, and management of infective endocarditis (IE) — a rare and potentially lethal […]

A new trial testing perioperative treatment with colchicine has shown no significant benefit on the co-primary outcomes of clinically important atrial fibrillation (AF) or myocardial injury […]

AMSTERDAM — The era of guidelines that recommended treatment with either a sodium-glucose cotransporter-2 (SGLT-2) inhibitor or a glucagon-like peptide-1 (GLP-1) receptor agonist in people with […]

When added to guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF), a traditional Chinese medicine called qiliqiangxin reduced the composite endpoint of cardiovascular death […]

A strategy of complete revascularization (CR) achieved superior 1-year outcomes compared with the culprit-lesion-only approach in older patients with acute myocardial infarction (MI) and multivessel disease […]